GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 month ...

UK health authorities are investigating pancreatitis cases linked to weight-loss drugs like Ozempic and Mounjaro. We spoke to doctors for clarity on risks, side effects, and the role of genetics.

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

The United Kingdom's health regulator is investigating weight loss jabs like Ozempic and Mounjaro after linking it to ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Ecnoglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist analogue, similar to the blockbuster obesity drug semaglutide. These drugs mimic the hormone GLP-1, which is involved in regulating ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Two major metabolic responses to glucagon have previously been demonstrated. 5 Normal subjects receiving 0.5 mg. intravenously show a ... and the departments of Preventive Medicine, Medicine and ...